ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
0,00%
Bitcoin
62.866,19
-0,80%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Maxcyte Inc (MXCT)

  7. Maxcyte Inc (MXCT) News

MXCT

Maxcyte (MXCT)

Maxcyte Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:MXCT
DatumZeitQuelleÜberschriftSymbolFirma
20/09/202418h02RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
16/09/202411h33Alliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
16/09/202408h00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
16/09/202408h00RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
06/09/202418h07RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
06/09/202412h33RNS Non-RegulatoryMaxCyte, Inc. Bioprocessing Conference ParticipationLSE:MXCTMaxcyte Inc
03/09/202416h38RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
29/08/202411h06RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
07/08/202415h10Alliance NewsAlliance NewsMaxCyte reaffirms guidance as revenue jumps 24% in first halfLSE:MXCTMaxcyte Inc
07/08/202408h05RNS Regulatory NewsMaxCyte, Inc. Filing of Form 10-QLSE:MXCTMaxcyte Inc
07/08/202408h00RNS Regulatory NewsMaxCyte, Inc. Second Quarter and Half-Year ResultsLSE:MXCTMaxcyte Inc
01/08/202417h31RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
31/07/202408h00RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/07/202410h15RNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
09/07/202410h14RNS Regulatory NewsMaxCyte, Inc. Change of Name of Nominated Adviser and BrokerLSE:MXCTMaxcyte Inc
03/07/202408h00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
02/07/202412h18RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
02/07/202408h00RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
27/06/202415h34RNS Regulatory NewsMaxCyte, Inc. Publication of Annual ReportLSE:MXCTMaxcyte Inc
14/06/202408h00RNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
12/06/202408h00RNS Regulatory NewsMaxCyte, Inc. Result of AGMLSE:MXCTMaxcyte Inc
11/06/202412h10Alliance NewsAlliance NewsIN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 sharesLSE:MXCTMaxcyte Inc
11/06/202408h00RNS Regulatory NewsMaxCyte, Inc. PDMR DealingLSE:MXCTMaxcyte Inc
03/06/202416h22RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
29/05/202414h05RNS Regulatory NewsMaxCyte, Inc. Participation in Upcoming Investor ConferenceLSE:MXCTMaxcyte Inc
22/05/202422h51Alliance NewsAlliance NewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech supplyLSE:MXCTMaxcyte Inc
22/05/202414h05RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
20/05/202408h00RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
14/05/202415h55RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
08/05/202410h46Alliance NewsAlliance NewsMaxCyte shares rise amid double-digit revenue increaseLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
NYSE
DIS
Walt Disney
TG
BAS
BASF
PM
XAUUSD
Gold vs US Dollar
NASDAQ
MSFT
Microsoft
TG
MBG
MercedesBenz
AMEX
XLV
Health Care Select Sector
TG
RHM
Rheinmetall
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
DBI
TDXP
Tec DAX
NYSE
MRK
Merck
DBI
DAX
DAX
FX
EURJPY
Euro vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten